Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes - Wikidata - awgldk - TriplyDB

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes

http://www.wikidata.org/entity/Q33937492

about

Detection and Characterization of Autoantibodies to Neuronal Cell-Surface Antigens in the Central Nervous System Clinical Spectrum of Stiff Person Syndrome: A Review of Recent Reports The Diagnosis and Treatment of Autoimmune Encephalitis Spinal-generated movement disorders: a clinical review Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms Lockjaw in stiff-person syndrome with autoantibodies against glycine receptors Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab.Neuronal central nervous system syndromes probably mediated by autoantibodies Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students Autoimmune encephalitis in psychiatric institutions: current perspectives Seizures and Epilepsies due to Channelopathies and Neurotransmitter Receptor Dysfunction: A Parallel between Genetic and Immune Aspects Neuroinflammation: Ways in Which the Immune System Affects the Brain Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies Autoimmune encephalopathies.Progressive Encephalomyelitis with Rigidity and Myoclonus in an Intellectually Disabled Patient Mimicking Neuroleptic Malignant Syndrome.Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy.Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease.Glycine receptor antibodies in PERM: a new channelopathy Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder A clinical approach to diagnosis of autoimmune encephalitis.Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.The recognition and treatment of autoimmune epilepsy in children.Therapy of paraneoplastic disorders of the CNS.Autoantibodies in movement and psychiatric disorders: updated concepts in detection methods, pathogenicity, and CNS entry.The role of complement in neurological and neuropsychiatric diseases.Immune therapy in autoimmune encephalitis: a systematic review.Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity.Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.Autoimmune encephalitis.NMDAR Encephalitis Following Herpes Simplex Virus Encephalitis.Limbic Encephalitis Associated With GAD65 Antibodies: Brief Review of the Relevant literature.NMDA receptor encephalitis and other antibody-mediated disorders of the synapse: The 2016 Cotzias Lecture.Pediatric Autoimmune Epileptic Encephalopathies.Autoimmune Movement Disorders: a Clinical and Laboratory Approach.Seizures and risk of epilepsy in autoimmune and other inflammatory encephalitis.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders.

P2860

Q26746048-FA714924-ABDE-46B7-84A2-793B4DFE9B09 Q26753841-5CB52262-B680-4D3A-B8D6-64BBB9698D88 Q26769676-0CCA042F-223F-41B4-A48E-01F2E602F409 Q26770774-611939D4-2488-4F78-A84F-2A960FD03419 Q26824216-6D9DE506-1F54-4295-A0B5-ACCCB5E8D498 Q27006941-AE14BB00-9292-48AD-A4ED-E1650A49AF40 Q27312191-0DD62C95-119D-4ED4-A3B9-3DA5C4F96D1A Q27323224-CCF90999-FEF1-4A00-AAFC-DDA0749F3A36 Q28072253-2E3AD70B-B2C3-4400-94AB-3668AA203CAE Q28077671-108AEE48-7519-4CDA-B365-54BF4B8BDFA0 Q28079666-8226D9D3-A5D7-4B97-AEE3-76EC7E28C621 Q28079865-342F1AE8-C992-45ED-B43D-7EEADF60AE31 Q28080620-3F6F0005-87DF-437D-9E92-30F0F9DD0781 Q28084055-CA671F29-49A8-4B94-9ACE-77D1BC476F70 Q30389491-2C25B55C-9860-4653-9B9E-4C4BE9C3BECD Q33701161-9805AE49-7AC4-41C8-9D07-CD464E563E6C Q34368647-95BFB7A0-60D2-4FE4-8C68-E77C1E89DE32 Q34453889-A077880F-FC89-49B1-8979-EEE66408D1E8 Q34481818-C62567A8-4364-46B1-AABB-DEE0A2F8E117 Q35677785-27C9F587-3FB1-4193-99FA-BDC42018E687 Q36175200-D754316A-A955-4CB3-8A17-D136524D8FF4 Q37250508-CB23F184-459E-471F-8AA9-F2E5D4272410 Q37343730-B5405C55-E02C-4F26-B21B-16900730370F Q38245624-082A201A-F3EE-4AB7-B47C-D93381F22EC7 Q38284599-01722B63-EC4A-4D78-AE81-AFB78815FAFB Q38329803-B732EF11-39C7-4AD7-8000-F37EA3C33F73 Q38530339-2ECDF2C1-AEE9-4285-B7D2-DAFD485D70BC Q38590250-365C4B69-D575-4B49-9869-C9BCFFAAB8A1 Q38630867-4AB846CB-2D8C-4BCF-BDA2-1CABC275219A Q38648896-BCBAF105-8848-4DCE-9476-C251296057B4 Q38726369-3C78D320-6F1F-4C94-BD23-AD744B4AF473 Q38743365-32BBAF46-D83E-4479-86A9-83F4D40EE748 Q38768583-44CE1112-017A-4FF6-AC78-ACDE4A8C444C Q38794169-B35FA6FC-2F6C-4DA7-B392-EC4F993879FD Q39030050-A44AC4B2-6195-4113-BA7F-E6C6238BE4C3 Q39068563-68549B94-DAD7-48C1-8580-18101B35F973 Q39102143-C20E32F2-0889-4B82-A491-5DA7398869A9 Q39149611-1DE72612-2787-40E5-B3C4-E008F3FA0562 Q39180685-55EAD6A7-0947-4FE4-8B18-47729D298596 Q39225440-C0E6FF73-10FF-4A55-A0A9-89048DC21978

P2860

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes

http://www.wikidata.org/entity/Q33937492

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Glycine receptor antibodies in ...... clinical features and outcomes

@ast

Glycine receptor antibodies in ...... clinical features and outcomes

@en

type

label

Glycine receptor antibodies in ...... clinical features and outcomes

@ast

Glycine receptor antibodies in ...... clinical features and outcomes

@en

prefLabel

Glycine receptor antibodies in ...... clinical features and outcomes

@ast

Glycine receptor antibodies in ...... clinical features and outcomes

@en

P1433

Q33937492-73C1F2D3-9A3F-457F-8959-A8E023CD7E9B

P1476

Q33937492-6298191A-272E-41B2-985A-D543DF4E7FFA

P2093

Q33937492-1453F5FF-2003-414A-AF0A-2B0FF2C34CC6

Q33937492-16A41D64-BF9C-43B5-B570-27F6F92F9730

Q33937492-4A8D6A37-8DB6-4C85-9AD2-0B52AD6A798A

Q33937492-541550FB-CF5F-4405-8CB0-414D59D660F6

Q33937492-59A5A854-C7DD-4646-9105-6AEA5A8C3490

Q33937492-8D864BA9-0E40-43B3-9E9F-3000CB48F3F8

Q33937492-90A50BB7-CE0C-4631-817E-EA640A3281C8

Q33937492-912AED6A-6650-405D-95F9-C8E5344B7B0D

Q33937492-AC993E5C-F4EB-441A-9AAC-4F15871C2CF7

Q33937492-B142A068-5666-43ED-A722-8DE8C84E8D2F

P2860

Q33937492-00487962-9FF5-4DE8-AEF6-FB5E2EF8F5BE

Q33937492-04B9B0EE-12AC-4E21-99A3-C40FABFD4D43

Q33937492-0DE15FC4-DA71-4540-87E6-0D669D6C85BC

Q33937492-0EF9A360-94C5-49F3-B28C-97C2CB4206E3

Q33937492-19C3A5B9-CD66-4D36-B6B9-D48C26D3602F

Q33937492-1D6D5237-2045-4445-ABE3-382CE0640975

Q33937492-25D21C55-5E4F-412F-B8EA-32D540AD26DD

Q33937492-2972DB00-2235-4478-BBEE-B62EAA101E1A

Q33937492-2BF9D248-5853-430A-BDBE-FF880C24EDDC

Q33937492-32E32D47-4BE5-42D4-A845-A49757314F3A

P304

Q33937492-279FD8D0-480D-4C5A-ADB4-57F66D79194E

P31

Q33937492-FE7F5127-D6FD-4D85-9903-A5A6E3F5C729

P356

Q33937492-A1718399-F057-4841-B4BC-4DD0109051C7

P407

Q33937492-FDFF4E65-C998-4CE6-A191-3ECDE68408D8

P433

Q33937492-66678FDF-EDDA-4291-A1AB-291D10A8DDB8

P478

Q33937492-80413C61-6CF2-4E23-8E14-38E2E2DBEFB0

P50

Q33937492-272E6365-52D1-4054-AA04-1EF721C5D6FC

Q33937492-6EC93B14-B5CC-4020-8033-42A37B80D958

P577

Q33937492-3CE1381A-BCE2-4A57-BAB8-0F885E2D4158

P5875

Q33937492-95C01EFD-D660-42DB-BF96-F309A9E2E1FB

P698

Q33937492-EDE34750-04F5-463F-A457-59C83D1B9072

P921

Q33937492-EDD1E950-7B05-4DE3-867B-2EE5A9BF0C8A

P932

Q33937492-430D5475-6274-4E71-B088-1CE94C1741C2

P356

P1433

P1476

Glycine receptor antibodies in ...... clinical features and outcomes

@en

P2093

Aisling Carr

http://www.w3.org/2001/XMLSchema#string

Alexander Carvajal-González

http://www.w3.org/2001/XMLSchema#string

Bethan Lang

http://www.w3.org/2001/XMLSchema#string

Ester Coutinho

http://www.w3.org/2001/XMLSchema#string

H-M Meinck

http://www.w3.org/2001/XMLSchema#string

M Isabel Leite

http://www.w3.org/2001/XMLSchema#string

Mark Woodhall

http://www.w3.org/2001/XMLSchema#string

Michael P Lunn

http://www.w3.org/2001/XMLSchema#string

Ming Lim

http://www.w3.org/2001/XMLSchema#string

Patrick Waters

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

A critical update on the immunopathogenesis of Stiff Person Syndrome

Native glycine receptor subtypes and their physiological roles

Childhood onset of stiff-man syndrome.

Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype.

Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens.

The stiff man and stiff man plus syndromes.

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

P304

2178-2192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWU142

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 8

http://www.w3.org/2001/XMLSchema#string

P478

137

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263297219

http://www.w3.org/2001/XMLSchema#string

P698

24951641

http://www.w3.org/2001/XMLSchema#string

P921

P932

4107739

http://www.w3.org/2001/XMLSchema#string